Garden State Investment Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.38M Buy
3,646
+122
+3% +$125K 0.79% 34
2026
Q1
$3.25M Buy
3,524
+84
+2% +$85.2K 0.71% 35
2025
Q4
$3.71M Buy
3,440
+251
+8% +$240K 0.82% 28
2025
Q3
$2.44M Buy
3,189
+40
+1% +$29.8K 0.54% 46
2025
Q2
$2.46M Sell
3,149
-282
-8% -$219K 0.62% 43
2025
Q1
$2.84M Buy
3,431
+1,125
+49% +$936K 0.91% 28
2024
Q4
$1.79M Sell
2,306
-328
-12% -$272K 0.53% 47
2024
Q3
$2.34M Buy
2,634
+372
+16% +$334K 0.75% 30
2024
Q2
$2.05M Buy
2,262
+291
+15% +$233K 0.71% 31
2024
Q1
$1.52M Buy
1,971
+211
+12% +$150K 0.56% 41
2023
Q4
$1.03M Buy
1,760
+468
+36% +$273K 0.41% 51
2023
Q3
$695K Sell
1,292
-30
-2% -$15.5K 0.32% 68
2023
Q2
$620K Buy
+1,322
New +$554K 0.24% 82

Other funds holding LLY

Garden State Investment Advisory Services's LLY Position: Q2 2026 in Review

Garden State Investment Advisory Services increased its Eli Lilly (LLY) stake by 3.5% in Q2 2026, buying an estimated $125K and bringing the position to 3,646 shares worth $4.38M. The position accounts for 0.79% of the portfolio, ranked #34.

Garden State Investment Advisory Services first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Garden State Investment Advisory Services held 3,646 shares of Eli Lilly worth $4.38M as of Q2 2026.
  • Garden State Investment Advisory Services bought 122 Eli Lilly shares in Q2 2026, an estimated $125K.
  • Eli Lilly made up 0.79% of Garden State Investment Advisory Services's portfolio in Q2 2026, its #34 holding.
  • Garden State Investment Advisory Services first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Garden State Investment Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.